DarioHealth director Dennis Matheis acquires 14,430 shares valued at $99,999.90PUBT·1 day ago, 04:28 PMDRIO-5.27%
Top Biotech Gainers: ZCMD Surges 190%, LABT Advances On Nu-3 Progress, ARWR Hits The Targetsrttnews·Jul 22 at 10:15 PMZCMD-9.40%DRIO-5.27%
Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq RulesUnusual Whales·Jul 22 at 07:18 AMDRIO-5.27%
DarioHealth plans to use USD 23.5 million offering proceeds for working capital, investments and acquisitionsPUBT·Jul 22 at 07:02 AMDRIO-5.27%
The AI Infrastructure Spillover and the Resilience of the Real EconomyGlobal Report·Jul 19 at 04:13 AMX0.00%NUAI-7.51%
M&A, AI Drug Discovery, and Late-Stage Clinical Readouts Define US Biotech Q2 TrajectoryGlobal Report·Jul 18 at 04:13 AMAMGN-1.39%CRSP+0.19%
Bankruptcies, Splits, and Real AI Revenue: Surviving the Market's FringesGlobal Report·Jul 17 at 04:12 AMZCMD-9.40%BTMCQ0.00%
Fortune 50 Employer Awards Dario Contract to Deliver AI-Powered Cardiometabolic Care Platform | DRIO Stock NewsStockTitan·Jul 15 at 10:30 PMDRIO-5.27%
Dario Expects Proprietary AI Engine DarioIQ™ to Increase Recurring Revenue from Existing Customers by 10-15% | DRIO Stock NewsStockTitan·Jul 12 at 10:30 PMDRIO-5.27%
DarioHealth Extends Executive Medical Leave, Adjusts LeadershipTip Ranks·Jul 10 at 04:29 PMDRIO-5.27%
